Can the Endocannabinoid System Help Explain Bruxism? What a New Neurobiological Model Proposes
A July 2026 Frontiers in Neuroscience paper proposes the endocannabinoid system bruxism neuromodulation hypothesis, suggesting ECS may regulate brain circuits behind bruxism. This is a translational model, not a clinical trial, highlighting a promising…
Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
A novel clinical trial is investigating tDCS cannabis use disorder schizophrenia treatment, targeting specific brain circuits involved in addiction and cognitive control. This innovative approach addresses the challenging dual diagnosis where traditional…
From Analgesia to Synaptic Remodeling: A Systematic Review of Acetaminophen’s Neuromodulatory Effects.
Neuro-related disorders will be rising globally. Current treatments have numerous limitations that can impair patients' quality of life. One of the key thera...
Phase 1 Open-Label Pilot Trial of H4 dTMS for Moderate-to-Severe Cannabis Use Disorder
Deep repetitive transcranial magnetic stimulation (dTMS) is being studied as a treatment for cannabis use disorder (CUD). This phase 1 open-label pilot trial evaluated H4 dTMS combined with standard care for adults with moderate-to-severe CUD. The study…
Non-vectorial integration of intersectional short-pulse stimulation enables enhanced deep brain modulation and effective seizure control.
Non vectorial integration is a novel technique improving deep brain modulation for seizure control. This approach overcomes limitations of traditional transcranial electrical stimulation. It offers promising advances in targeted neuromodulation therapies.
Phase 1 Open-Label Pilot Trial of H4 dTMS for Cannabis Use Disorder
Deep repetitive transcranial magnetic stimulation cannabis use is being studied as a novel intervention for cannabis use disorder. This phase 1 open-label pilot trial evaluates safety and feasibility. The study targets adults with moderate-to-severe…